German researchers have proposed a mechanism for the vaccine-induced thrombosis and thrombocytopenia (VITT) observed in a minority of people receiving the AstraZeneca and Johnson & Johnson COVID-19 vaccines. The researchers said the fundamental difference between the mRNA and adenoviral vector-based vaccines was in their delivery to either the cytosol or nucleus. “Most importantly, the RNA ...
VITT mechanism shows the way to avoid COVID-19 vaccine thrombosis
By Mardi Chapman
1 Jun 2021